CLINICAL_TRIALS
trial_result
· 2016-12-16
Clinical Trial Update: F17464 in Acute Schizophrenia Trial [Phase 2]
Summary
A Phase 2 clinical trial evaluating F17464 for acute schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pierre Fabre Medicament | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED